Results 131 to 140 of about 2,631,955 (205)

MYD88 mutations are associated with a high tumor mutational burden

Annals of Oncology, 2016
A.M. Goodman, R. Kurzrock, A. Boichard
openaire   +1 more source

Systemic inflammation biomarkers can identify high tumor mutation burden in lung adenocarcinoma. [PDF]

BMC Cancer
Fang J, Li Q, Xu N, Yang X, Zhang Q, Chen Y, Li H.   +6 more
europepmc   +1 more source

Impact of tumor mutation burden on the prognosis of patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization combined with immunotherapy and anti-angiogenic drugs. [PDF]

J Gastrointest Oncol
Huang XW, Wang DJ, Cai BZ.
europepmc   +1 more source

Conjunctival melanoma genomic analysis reveals intermediate tumor mutation burden and genomic overlap with cutaneous melanoma. [PDF]

NPJ Precis Oncol
Dimitriou F, Wu X, Nagarajan P, Glitza IC, Zhao L, Ning J, Patel SP, Wargo JA, Futreal A, Woodman S, McQuade JL, Esmaeli B.   +11 more
europepmc   +1 more source

Case Report: Mixed ductal-lobular carcinoma consisting of invasive lobular carcinoma with a glycogen-rich clear cell pattern and elevated tumor mutation burden. [PDF]

Front Oncol
Kawachi K, Tang X, Kasajima R, Katayama K, Yamaguchi R, Yamaguchi K, Furukawa Y, Imoto S, Miyano S, Yoshioka E, Washimi K, Okubo Y, Sato S, Yokose T, Miyagi Y.   +14 more
europepmc   +1 more source

Assessment of tumor mutation burden based on whole-exome sequencing of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid in advanced non-small cell lung cancer treated with pembrolizumab: a prospective, multicenter, observational study. [PDF]

Transl Lung Cancer Res
Kim H, Hur J, Kim WS, Kim IA, Park D, Oh IJ, Noh SJ, Bang H, Lee KY.   +8 more
europepmc   +1 more source

Clinical outcomes of tumor-agnostic targeting of BRAF, tumor mutation burden-high, and RET. [PDF]

ESMO Open
Ronaghy A, Crimini E, Holla VR, Mills Shaw KR, Doefler AM, Campbell E, Yang RK, Iorgulescu JB, Patel KP, McPherson DD, Ning J, Meric-Bernstam F, Karp DD.   +12 more
europepmc   +1 more source

TMBquant: an explainable AI-powered caller advancing tumor mutation burden quantification across heterogeneous samples. [PDF]

Brief Bioinform
Wang S, Wang X, Zhu X, Wang X, Liu Y, Zhao M, Chang Z, Shao Y, Zhang H, Yang S, Wang J.   +10 more
europepmc   +1 more source

740 Biomarkers diverging between tumor mutation burden and microsatellite instability

Journal for ImmunoTherapy of Cancer, 2020
Jason Ding, Nihir Patel
doaj   +1 more source

Characterization of the Neoantigen Profile in a Tumor Mutation Burden-high Melanoma Patient With Multiple Metastases. [PDF]

Cancer Genomics Proteomics
Yoshikawa S, Maeda C, Iizuka A, Ikeya T, Yamashita K, Ashizawa T, Kanematsu A, Miyata H, Kikuchi Y, Urakami K, Ohshima K, Nagashima T, Yamaguchi K, Kiyohara Y, Akiyama Y.   +14 more
europepmc   +1 more source